Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Skin symptoms often reveal hormonal imbalances in PCOS.

Tazarotene gel may be more effective for acne than adapalene gel.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

Acne patients have higher mTOR gene expression.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

The document explains various skin conditions and their treatments.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Adult female acne is complex and requires a combination of treatments for effective management.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

α-mangostin nanoparticles improved acne with minimal irritation.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Polymer-based nanocarriers can improve acne treatment by delivering drugs through hair follicles more effectively.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Restoring skin microbial balance may help treat acne.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Dutasteride improved both hair loss and acne in two young men.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Improving skin barrier and using antifungal treatments can help manage dandruff.